Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer.

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer.

The TMPRSS2/ERG (T/E) fusion gene is present in the majority of all prostate cancers (PCa). We have shown previously that NF-kB signaling is highly activated in these T/E fusion expressing cells via phosphorylation of NF-kB p65 Ser536 (p536). We therefore hypothesize that targeting NF-kB signaling m...

Full description

Bibliographic Details
Main Authors: Longjiang Shao, Zhansong Zhou, Yi Cai, Patricia Castro, Olga Dakhov, Ping Shi, Yaoxia Bai, Huixiang Ji, Wenhao Shen, Jianghua Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3590152?pdf=render

Internet

http://europepmc.org/articles/PMC3590152?pdf=render

Similar Items